当前位置: 首页 > 期刊 > 《中国卫生》 > 2013年第17期
编号:12818111
克罗米芬抵抗多囊卵巢综合症临床促排卵体会(2)
http://www.100md.com 2013年9月1日 中国卫生 2013年第17期
     参考文献:

    [1] Shoham Z,Paltel A,Jacobs HS.Polycystic ovarian syndrome:safety and effectiveness of stepwise and Low- dose administration of purified follicle- stimulating hormone〔J〕.Fertile steril,1991,55(6):1051.

    [2] The R otterdam ESHR E/ASR M- Sponsored PCOS Workshop Group.R evised 2003 consensus on diagnostic criteria and long- term health risk related to polycystic ovary syndrome〔J〕.Fertile Steril,2004,84(1):19.

    [3] 陈蔚林,张以文,戴晴,等,促卵泡激素低剂量缓增方案治疗耐氯米芬多囊卵巢综合症无排卵不孕症〔J〕。中华妇产科杂志,2000,35(10):388。

    [4] Balasch J,Tur R ,Creus M,et al.Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropinstimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy.Gynecol Endocrinol,1994,8(1):7- 12.

    [5] Itskovitz- Eldor J,Levron J,Kol S.Use of gonadotropin releasing hormone agonist to couse ovulation and prevent the ovarian hyperstimulation syndrome.Clin Obstet Gynecol,1993,36(3):701- 10.

    [6] 董华,陈士岭,刑福祺.促性腺激素释放激素激动剂在多囊卵巢综合征促排卵高危周期中的应用.中华妇产科杂志,1999,34(2):94- 6., 百拇医药(阳谷)
上一页1 2